The Worldwide Market for Enteral Feeding Formulas (2019-2025): Disease-Specific Formula Expected to Emerge at the Fastest CAGR of 8.6% Over the Forecast Period

4/18/2019, 1:15 PM (Source: GlobeNewswire)

Dublin, April 18, 2019 (GLOBE NEWSWIRE) -- The "Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product (Standard, Disease-specific), By Stage, By Application, By End Use, By Region, And Segment Forecasts, 2019 - 2025" report has been added to's offering.

The global enteral feeding formulas market size is expected to reach USD 8.71 billion by 2025, at a CAGR 7.2% over a forecast period.

It is majorly driven by growing prevalence of chronic diseases including cancer, diabetes, inflammatory bowel disease, liver disease, and neurological conditions. Manufacturers are increasingly focusing on developing formulas that cater to specific therapeutic needs of these patients. Rise in number of preterm births is also one of the significant factors that propel the product demand to meet nutritional requirements of the newborns.

Increasing number of home care and nursing care centers also indicates the surge in demand for these formulas, as a large number of chronically ill as well as geriatric patients are the key consumers for these products. Growing demand for these products for treating conditions associated with pregnancy also contributes to market growth. In addition, recent product developments and rise in number of new product launches may positively impact the growth.

Rise in prevalence of hospital associated malnutrition among both adults and children drives the demand for enteral feeding formulas. Increasing implementation of the number of government programs for creating awareness regarding enteral tube feeding may also support increasing adoption. Moreover, favorable reimbursement policies in developed countries cover tube feeding procedures that may impel the enteral feeding formulas market over the forecast period.

Further key findings from the report suggest:

  • Disease-specific formula segment is expected to emerge at the fastest CAGR of 8.6% over the forecast period owing to high prevalence of chronic diseases coupled with recent product developments
  • Adults segment held the largest market share in terms of revenue in 2018 due to high availability and increased adoption of tube feeding formulas among adults
  • In 2018, oncology led the application segment with the largest revenue share owing high prevalence of cancer induced malnutrition
  • Home care end use segment is expected to grow lucratively over the forecast period
  • North America held the largest revenue share in 2018 owing to favorable reimbursement policies and rising burden of cardiovascular diseases
  • Asia Pacific is expected to witness the fastest CAGR 8.7% over the forecast period
  • The enteral feeding formulas market is fairly competitive with the presence of companies such as Abbott; Nestle Health Science, Danone Nutricia; Fresenius Kabi AG; and Meiji Holding and Co.

Key Topics Covered

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.4 Information Analysis
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Enteral Feeding Formulas Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.2 Penetration & Growth Prospects Mapping
3.3 User Perspective Analysis
3.4 List of Key End-users
3.5 Regulatory Framework
3.6 Enteral Feeding Formulas Market Dynamics
3.7 Enteral Feeding Formulas Market Analysis Tools

Chapter 4 Enteral Feeding Formulas Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.4 Public Companies
4.5 Private Companies

Chapter 5 Enteral Feeding Formulas Market:Product Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Product Market Share Analysis, 2018 & 2025
5.3 Segment Dashboard
5.4 Global Enteral Feeding Formulas Market, by Product, 2014 to 2025 (USD Million)

Chapter 6 Enteral Feeding Formulas Market:Stage Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Stage Market Share Analysis, 2018 & 2025
6.3 Segment Dashboard
6.4 Market Revenue Estimates and Forecasts by Stage, 2014 to 2025 (Revenue USD Million)

Chapter 7 Enteral Feeding Formulas Market:Application Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Application Market Share Analysis, 2018 & 2025
7.3 Segment Dashboard
7.4 Market Revenue Estimates and Forecasts by Application, 2014 to 2025 (Revenue USD Million)

Chapter 8 Enteral Feeding Formulas Market:End Use Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Application Market Share Analysis, 2018 & 2025
8.3 Segment Dashboard
8.4 Market Revenue Estimates and Forecast by End Use, 2014 to 2025 (Revenue:USD Million)

Chapter 9 Enteral Feeding Formulas Market: Regional Estimates & Trend Analysis, by product, by stage, by application, and by end-user
9.1 Regional Enteral Feeding Formulas Market Snapshot
9.2 List of Key Players, by Region
9.3 Regional Estimates and Forecast, 2014 - 2025 (USD Million)
9.4 North America
9.5 Europe
9.6 Asia Pacific
9.7 Latin America
9.8 MEA
9.9 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 Abbott
10.1.2 Nestle S.A.
10.1.3 B. Braun Melsungen AG
10.1.4 Danone S.A.
10.1.5 Fresenius Kabi AG
10.1.6 Hormel Foods Corporation
10.1.7 Meiji Holding and Co.
10.1.8 Victus Inc.
10.1.9 Global Health Products
10.1.10 Mead Johnson Nutrition
10.2 List of Other Key Players

For more information about this report visit

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Medical Devices


Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.